SAN DIEGO, CA, January 04, 2010
/24-7PressRelease/ -- Eidogen-Sertanty, Inc., a San Diego-based computational drug discovery solutions provider, announced today the release of iKinase, an iPhone/iPod-Touch application.
iKinase provides sample structure activity data from Eidogen-Sertanty's Kinase Knowledgebase (KKB). With iKinase, a user can search for Kinase targets by standardized names, identify top-active molecules for each target, and drill-down into more detail.
iKinase can be downloaded within iTunes and/or Apple's App Store.
Eidogen-Sertanty contact:
Steve Muskal
760-651-2885
pr@eidogen-sertanty.com
About Eidogen-Sertanty
Eidogen-Sertanty, formed in March 2005 from the merger of Eidogen and Sertanty, is a privately held company providing pioneering knowledge-driven discovery solutions to biotechnology and pharmaceutical organizations. Eidogen-Sertanty's unique and powerful suite of software, databases, and drug discovery services enable customers and collaborators to apply a knowledge-driven discovery approach to a variety of workflows and processes, including target selection and prioritization, library building and compound prioritization, and lead design and optimization. To find out more about Eidogen-Sertanty and their products and services, please visit http://www.eidogen-sertanty.com.
---
Press release service and press release distribution provided by http://www.24-7pressrelease.com# # #
Read more Press Releases from Steven Muskal:
